Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

The present study evaluated the safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor under development for the treatment of Alzheimer's disease (AD) in otherwise healthy young and elderly Chinese subjects. The study of young subjects included...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Hongjie, Yu, Chengyin, Zhu, Huijuan, Ding, Qichen, Cai, Yuting, Jing, Jiao, Xu, Xin, Guo, Runcong, Zhang, Haiyan, Liu, Hong, Chen, Xiaoyan, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175976/
https://www.ncbi.nlm.nih.gov/pubmed/36798012
http://dx.doi.org/10.1111/cts.13490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175976/
https://www.ncbi.nlm.nih.gov/pubmed/36798012
http://dx.doi.org/10.1111/cts.13490

Ejemplares similares